共 62 条
[41]
McLellan R, 1989, Obstet Gynecol Surv, V44, P711, DOI 10.1097/00006254-198910000-00002
[42]
MONSON RR, 1973, CANCER, V31, P630, DOI 10.1002/1097-0142(197303)31:3<630::AID-CNCR2820310321>3.0.CO
[43]
2-B
[44]
RELATIONSHIP BETWEEN SURGICAL PATHOLOGICAL RISK-FACTORS AND OUTCOME IN CLINICAL STAGE-I AND STAGE-II CARCINOMA OF THE ENDOMETRIUM - A GYNECOLOGIC ONCOLOGY GROUP-STUDY
[J].
GYNECOLOGIC ONCOLOGY,
1991, 40 (01)
:55-65
MORROW, CP
;
BUNDY, BN
;
KURMAN, RJ
;
CREASMAN, WT
;
HELLER, P
;
HOMESLEY, HD
;
GRAHAM, JE
.
[45]
MORROW CP, 1973, OBSTET GYNECOL, V42, P399
[46]
ESTROGEN REPLACEMENT THERAPY .2. PROSPECTIVE-STUDY IN THE RELATIONSHIP TO CARCINOMA AND CARDIOVASCULAR AND METABOLIC PROBLEMS
[J].
OBSTETRICS AND GYNECOLOGY,
1979, 54 (01)
:74-79
NACHTIGALL, LE
;
NACHTIGALL, RH
;
NACHTIGALL, RD
;
BECKMAN, EM
.
[47]
NG ABP, 1973, AM J CLIN PATHOL, V59, P765
[48]
ONSRUD M, 1976, Gynecologic Oncology, V4, P222, DOI 10.1016/0090-8258(76)90064-0
[49]
Palermo V G, 1985, Diagn Cytopathol, V1, P5, DOI 10.1002/dc.2840010104
[50]
REAGAN JW, 1980, ACTA CYTOL, V24, P87